NCT05899530 is a NA clinical trial of Invisalign in Expansion of Maxillary Arch, sponsored by Al-Azhar University.

Who is sponsoring NCT05899530?

NCT05899530 is sponsored by Al-Azhar University.

What drugs are being tested in NCT05899530?

Interventions in NCT05899530: Invisalign, Conventional expander.

What condition does NCT05899530 study?

NCT05899530 studies Expansion of Maxillary Arch, Maxillary Hypoplasia.

Is NCT05899530 still recruiting?

NCT05899530 is currently status unknown. Last updated 13 June 2023.

Last reviewed 2023-06-13 · How we verify

NCT05899530

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dentoskeletal Changes Expansion Using Invisalign Versus Conventional Expander

Status unknown NA Last updated 13 June 2023

What this trial tests

NA trial testing Invisalign in Expansion of Maxillary Arch in 20 participants. Status unknown.

Timeline

22 July 2023

Primary endpoint
30 March 2024

31 May 2024

Quick facts

Lead sponsor	Al-Azhar University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	22 July 2023
Primary completion	30 March 2024
Estimated completion	31 May 2024

Drugs / interventions tested

Invisalign
Conventional expander

Conditions studied

Expansion of Maxillary Arch — all drugs for Expansion of Maxillary Arch →
Maxillary Hypoplasia — all drugs for Maxillary Hypoplasia →

Sponsor

Al-Azhar University

Who can join

Adults 12 to 16, any sex, with Expansion of Maxillary Arch or Maxillary Hypoplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cbct evaluation of dentoskeletal changes after expansion using Invisalign versus conventional expander

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05899530 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
Last refreshed: 13 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05899530.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing